Showing results (151-160 of 311) with videos related to

Sort By:
Pageof 32
Parkinsonism & Related Disorders|August 2, 2016
Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controlsMichael Zech, Angela Jochim, Sylvia Boesch, et al.
Neurology|September 3, 2013
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohortBrit Mollenhauer, Ellen Trautmann, Friederike Sixel-Döring, et al.
Annals of Neurology|August 2, 2003
Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob diseaseJens Wiltfang, Hermann Esselmann, Alexander Smirnov, et al.
Neurobiology of Disease|May 19, 2015
Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker InitiativeBrice Laurens, Radu Constantinescu, Roy Freeman, et al.
Molecular Neurobiology|March 22, 2017
Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob DiseaseFranc Llorens, Niels Kruse, André Karch, et al.
NPJ Parkinson'S Disease|September 26, 2025
Sleep stage mixing is associated with poor prognosis in early Parkinson's diseasePauline Dodet, Emmanuel During, Isabelle Arnulf, et al.
Annals of Neurology|May 6, 2026
Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers InitiativeLana M Chahine, Roy N Alcalay, Ethan G Brown, et al.
Nucleic Acids Research|October 11, 2019
SEAweb: the small RNA Expression Atlas web applicationRaza-Ur Rahman, Anna-Maria Liebhoff, Vikas Bansal, et al.
Medrxiv : the Preprint Server for Health Sciences|January 2, 2026
How many do we miss? - Evaluation of age at onset and family history as selection criteria for genetic testing in Parkinson's diseaseAlexander Balck, Eva-Juliane Vollstedt, Ana Westenberger, et al.
NPJ Parkinson'S Disease|October 22, 2022
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortTanya Simuni, Kalpana Merchant, Michael C Brumm, et al.
Pageof 32